Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
The global nephrology community recognises the need for a cohesive plan to address the
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
[HTML][HTML] Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care
…, S Naicker, MJ Germain, DJ O'donoghue… - Kidney international, 2015 - Elsevier
Patients with advanced chronic kidney disease (CKD) have a high burden of physical and
psychosocial symptoms, poor outcomes, and high costs of care. Current paradigms of care for …
psychosocial symptoms, poor outcomes, and high costs of care. Current paradigms of care for …
Estimating the financial cost of chronic kidney disease to the NHS in England
…, B Bray, J Medcalf, DJ O'Donoghue… - Nephrology Dialysis …, 2012 - academic.oup.com
Background Chronic kidney disease (CKD) is a major challenge for health care systems
around the world, and the prevalence rates appear to be increasing. We estimate the costs of …
around the world, and the prevalence rates appear to be increasing. We estimate the costs of …
Serum phosphate and mortality in patients with chronic kidney disease
…, J Hegarty, J New, DJ O'Donoghue… - Clinical Journal of the …, 2010 - journals.lww.com
Background and objectives: Higher phosphate is associated with mortality in dialysis patients
but few prospective studies assess this in nondialysis patients managed in an outpatient …
but few prospective studies assess this in nondialysis patients managed in an outpatient …
The economic impact of acute kidney injury in England
…, B Matthews, D O'Donoghue - Nephrology Dialysis …, 2014 - academic.oup.com
Background Acute kidney injury (AKI) is one of the most common complications affecting
hospital inpatients around the world. It is associated with high mortality and adverse long-term …
hospital inpatients around the world. It is associated with high mortality and adverse long-term …
Early chronic kidney disease: diagnosis, management and models of care
OJ Wouters, DJ O'donoghue, J Ritchie… - Nature Reviews …, 2015 - nature.com
Chronic kidney disease (CKD) is prevalent in many countries, and the costs associated with
the care of patients with end-stage renal disease (ESRD) are estimated to exceed US$1 …
the care of patients with end-stage renal disease (ESRD) are estimated to exceed US$1 …
The unrecognized prevalence of chronic kidney disease in diabetes
…, JM Gibson, PA Kalra, DJ O'Donoghue… - Nephrology Dialysis …, 2006 - academic.oup.com
Background. Diabetes mellitus and chronic kidney disease (CKD) are common and exhibit
synergistic associations with premature mortality. Current diabetes guidelines in the UK …
synergistic associations with premature mortality. Current diabetes guidelines in the UK …
[HTML][HTML] The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) …
…, AE Moran, M Nguyen, GT Obrador, D O'Donoghue… - Kidney international, 2021 - Elsevier
Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular
and all-cause mortality. Unlike other chronic diseases with established strategies for …
and all-cause mortality. Unlike other chronic diseases with established strategies for …
Developing a set of core outcomes for trials in hemodialysis: an international Delphi survey
…, WC Winkelmayer, B Sautenet, D O'Donoghue… - American Journal of …, 2017 - Elsevier
Background Survival and quality of life for patients on hemodialysis therapy remain poor
despite substantial research efforts. Existing trials often report surrogate outcomes that may not …
despite substantial research efforts. Existing trials often report surrogate outcomes that may not …
[HTML][HTML] Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial
…, J Feehally, GJ Gaskin, DRW Jayne, D O'Donoghue… - The Lancet, 2013 - thelancet.com
Background Membranous nephropathy leads to end-stage renal disease in more than 20%
of patients. Although immunosuppressive therapy benefits some patients, trial evidence for …
of patients. Although immunosuppressive therapy benefits some patients, trial evidence for …